614 participants
Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in Subjects With Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-12-24
- Start Date:
- 2023-05-23
- Completion:
- 2024-11-22
Conditions
- Complicated Urinary Tract Infection
- Acute Pyelonephritis
- cUTI
- AP
Interventions
- DRUG